CXCL10/IP-10 in Infectious Diseases Pathogenesis and Potential Therapeutic Implications

By Mingli Liu, Shanchun Guo, J. Hibbert, V. Jain, Neeru Singh, Nana O. Wilson, J. Stiles. Cytokine & growth factor reviews, 2011

759 citations recorded by the source corpus.

C-X-C motif chemokine 10 (CXCL10) also known as interferon γ-induced protein 10 kDa (IP-10) or small-inducible cytokine B10 is a cytokine belonging to the CXC chemokine family. CXCL10 binds CXCR3 receptor to induce chemotaxis, apoptosis, cell growth and angiostasis. Alterations in CXCL10 expression levels have been associated with inflammatory diseases including infectious diseases, immune dysfunction and tumor development. CXCL10 is also recognized as a biomarker that predicts severity of various diseases. A review of the emerging role of CXCL10 in pathogenesis of infectious diseases revealed diverse roles of CXCL10 in disease initiation and progression. The potential utilization of CXCL10 as a therapeutic target for infectious diseases is discussed.

Subfields: Animal Science and Zoology, Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/2688f5446a64d201ae00dad18523b362b41aee65

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. A. Zlotnik
2. O. Yoshie

In Oncology

1. A. Zlotnik
2. O. Yoshie

Citations in the corpus

• The Chemokine Superfamily Revisited (2012, positive): “For example, CCR9 antagonists are currently in clinical trials for inflammatory bowel diseases (Proudfoot et al., 2010), and CXCR3 antagonists (presumably because they target Th1 cell responses) also show promise in other indications (Liu et al., 2011).”